PUMA BIOTECHNOLOGY, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Puma Biotechnology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Puma Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.58M, a 5.34% increase year-over-year.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $6.08M, a 3.79% increase from 2022.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $5.86M, a 2.29% increase from 2021.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2021 was $5.73M, a 2.91% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.58M +$80K +5.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $1.5M +$51K +3.53% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q1 2022 $1.45M +$67K +4.86% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $1.38M -$20K -1.43% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q1 2020 $1.4M +$68K +5.11% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q1 2019 $1.33M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.